Teladoc Health, Inc.
TDOC
$7.68
$0.496.82%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.64% | -2.59% | -3.03% | -2.99% | -1.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.64% | -2.59% | -3.03% | -2.99% | -1.53% |
| Cost of Revenue | 1.32% | 1.18% | -2.32% | -3.34% | -1.30% |
| Gross Profit | -2.87% | -4.22% | -3.33% | -2.85% | -1.62% |
| SG&A Expenses | -1.41% | -5.65% | 5.78% | -4.24% | -7.78% |
| Depreciation & Amortization | -3.69% | -10.24% | -8.20% | -5.02% | 27.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.98% | -5.38% | -1.13% | -5.27% | -2.78% |
| Operating Income | 6.42% | 28.72% | -40.90% | 30.99% | 16.67% |
| Income Before Tax | 95.15% | -40.49% | -89.84% | 45.44% | -1,160.85% |
| Income Tax Expenses | -299.87% | -778.62% | -93.23% | 131.40% | 507.98% |
| Earnings from Continuing Operations | 96.10% | -13.58% | -67.56% | 41.70% | -1,185.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 96.10% | -13.58% | -67.56% | 41.70% | -1,185.22% |
| EBIT | 6.42% | 28.72% | -40.90% | 30.99% | 16.67% |
| EBITDA | -83.90% | 10.91% | -73.01% | 1.70% | 600.57% |
| EPS Basic | 96.23% | -9.40% | -61.03% | 43.87% | -1,139.50% |
| Normalized Basic EPS | 25.85% | 36.52% | -133.95% | 48.61% | 24.59% |
| EPS Diluted | 96.23% | -9.40% | -61.03% | 43.87% | -1,139.50% |
| Normalized Diluted EPS | 25.85% | 36.52% | -133.95% | 48.61% | 24.59% |
| Average Basic Shares Outstanding | 3.34% | 3.83% | 4.04% | 3.86% | 3.69% |
| Average Diluted Shares Outstanding | 3.34% | 3.83% | 4.04% | 3.86% | 3.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |